11.1.5. Opportunities Explained
11.1.5.1. Varian Could Expand Its Position with Imaging Components Business' Spin-Off:
11.1.5.2. Acquisitions Likely to Enhance Varian's Oncology and Imaging Businesses:
11.1.5.3. Expansion in Operations in the U.S.:
11.1.5.4. Increasing Incidence of Cancer to Drive Global Radiation Therapy Equipment Market:

11.1.6. Threats Explained
11.1.6.1. Intense Competition Could Affect Varian'S Market Share and Results of Operation:
11.1.6.2. Increasing Medical Costs in Cancer Treatment and Care: 259
11.1.7. Revenue Analysis
11.1.8. Product Portfolio
11.1.9. Recent Developments
11.1.10. Analysis
11.2. Elekta Ab
11.2.1. Company Overview
11.2.2. Revenue Analysis
11.2.3. Product Portfolio
11.2.4. Recent Developments
11.2.5. Analysis
11.3. Nanobiotix
11.3.1. Company Overview
11.3.2. Revenue Analysis
11.3.3. Product Portfolio
11.3.4. Recent Developments
11.3.5. Analysis
11.4. Accuray, Inc.
11.4.1. Company Overview
11.4.2. Revenue Analysis
11.4.3. Product Portfolio
11.4.4. Recent Developments
11.5. Brainlab Ag
11.5.1. Company Overview
11.5.2. SWOT (Strength, Weakness, Opportunities and Threats)
11.5.3. Drivers Explained
11.5.3.1. Strong Partner Network:
11.5.3.2. Established Presence in Markets:
11.5.4. Weaknesses Explained
11.5.4.1. Product Safety Concerns:
11.5.5. Opportunities Explained
11.5.5.1. Strategic Initiatives:
11.5.6. Threats Explained
11.5.6.1. Rapid Technological Changes:
11.5.6.2. Stringent Government Regulations:
11.5.7. Revenue Analysis
11.5.8. Product Portfolio
11.5.9. Recent Developments
11.6. Ion Beam Applications Sa
11.6.1. Company Overview
11.6.2. Revenue Analysis
11.6.3. Product Portfolio
11.6.4. Recent Developments
11.7. Mevion Medical Systems, Inc.
11.7.1. Company Overview
11.7.2. Revenue Analysis
11.7.3. Product Portfolio
11.7.4. Recent Developments
11.8. Isoray Medical, Inc.
11.8.1. Company Overview
11.8.2. Revenue Analysis
11.8.3. Product Portfolio
11.8.4. Recent Developments
11.9. Nordion (Canada) Inc.
11.9.1. Company Overview
11.9.2. SWOT (Strength, Weakness, Opportunities and Threats)
11.9.3. Drivers Explained
11.9.3.1. Established Presence in Gamma Irradiation Industry:
11.9.4. Weaknesses Explained
11.9.4.1. Radiation Exposure Claims and Other Disputes:
11.9.5. Opportunities Explained
11.9.5.1. Strategic Initiatives:
11.9.6. Threats Explained
11.9.6.1. Rapid Technological Changes:
11.9.6.2. Stringent Government Regulations:
11.9.6.3. Stiff Competition:
11.9.7. Revenue Analysis
11.9.8. Product Portfolio
11.9.9. Recent Developments
11.10. Raysearch Laboratories Ab
11.10.1. Company Overview
11.10.2. Revenue Analysis
11.10.3. Product Portfolio
11.10.4. Recent Developments
11.11. Precisis Ag
11.11.1. Company Overview
11.11.2. Revenue Analysis
11.11.3. Product Portfolio
11.11.4. Recent Developments

12. Related Reports



Companies Mentioned


Accuray, Inc.
Brainlab AG
C. R. Bard, Inc.
CIVCO Medical Solutions

Rad Oncology Homepage